LCM
RDY icon

Logan Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Logan Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$569K Buy
+41,100
New +$572K 0.02% 238

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Logan Capital Management's RDY Position: Q1 2026 in Review

Logan Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 41,100 shares — an estimated $572K sold.

Logan Capital Management first reported a position in RDY in Q2 2015 and held it in 42 quarters. The position peaked at $1.34M in Q3 2021. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Logan Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 41,100 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $572K.
  • Logan Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 42 quarters.
  • Logan Capital Management's Dr. Reddy's Laboratories position peaked at $1.34M in Q3 2021.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.